CDC logo, Safer Healthier People  CDC HomeCDC SearchCDC Health Topics A-Z
NIOSH - National Institute for Occupational Safety and Health

Search NIOSH  |  NIOSH Home  |  NIOSH Topics  |  Site Index  |  Databases and Information Resources  |  NIOSH Products  |  Contact Us






Lithium chloride

RTECS #: OJ5950000

CAS #: 7447-41-8


UPDATE: May 2009 MW: 42.39 MF: ClLi


NOTE:

TABLE OF CONTENTS:
  1. SYNONYMS:
  2. SKIN AND EYE IRRITATION DATA:
  3. MUTATION DATA:
  4. REPRODUCTIVE EFFECTS DATA:
  5. TUMORIGENIC DATA:
  6. ACUTE TOXICITY DATA:
  7. OTHER MULTIPLE DOSE DATA:
  8. NIOSH DOCUMENTATION AND SURVEILLANCE:
  9. STATUS IN FEDERAL AGENCIES:
  10. REFERENCES:

SYNONYMS:

  1. Chlorku litu (Polish)
  1. Chlorure de lithium (French)


SKIN AND EYE IRRITATION DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
eye
rabbit
100 mg/24 hour moderate 28ZPAK -,7,1972
skin
rabbit
500 mg/24 hour severe 28ZPAK -,7,1972


MUTATION DATA AND REFERENCES:

SYSTEM TEST ROUTE/
ORGANISM/
TISSUE
DOSE REFERENCE
cytogenetic analysis human lymphocyte 50 mg/L TJADAB 13,131,1976
cytogenetic analysis oral
mouse
212 g/kg/3 day- intermittent CYTOAN 54,245,1989
DNA inhibition human lymphocyte 50 mg/L TJADAB 13,131,1976
DNA inhibition human HeLa cell 70 mmol/L MUREAV 92,427,1982
gene conversion and mitotic recombination Saccharomyes cerevisiae 9 mmol/L MUTAEX 1,21,1986
sister chromatid exchange oral
mouse
21 mg/kg/3 day- intermittent CYTOAN 54,245,1989
sex chromosome loss and nondisjunction Saccharomyes cerevisiae 3 mmol/L MUTAEX 1,21,1986


REPRODUCTIVE EFFECTS DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
intraperitoneal
mouse
lowest published toxic dose: 320 mg/kg (6-7 day pregnant) Reproductive: Effects on newborn: Other neonatal measures or effects JPETAB 101,362,1951
intraperitoneal
rat
lowest published toxic dose: 41,360 mg/kg (1 day male) Reproductive: Effects on fertility: Mating performance (e.g., # sperm positive females per # females mated; # copulations per # estrus cycles) DEPBA5 20,603,1987
intraperitoneal
rat
lowest published toxic dose: 809 mg/kg (9-16 day pregnant) Reproductive: Specific developmental abnormalities: Eye, ear

Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue)

Reproductive: Other effects to embryo or fetus
TJADAB 4,151,1971
intraperitoneal
rat
lowest published toxic dose: 979 mg/kg (7-16 day pregnant) Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) TJADAB 4,151,1971
intraperitoneal
rat
lowest published toxic dose: 1 gm/kg (7-11 day pregnant) Reproductive: Effects on fertility: Abortion

Reproductive: Effects on embryo or fetus: Fetal death
CRSBAW 167,183,1973
intraperitoneal
rat
lowest published toxic dose: 1,250 mg/kg (7-11 day pregnant) Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth) CRSBAW 167,183,1973
oral
mouse
lowest published toxic dose: 66 gm/kg (1-21 day pregnant/21 day after birth) Reproductive: Specific developmental abnormalities: Central nervous system

Reproductive: Effects on newborn: Biochemical and metabolic

Reproductive: Effects on newborn: Physical
PHBHA4 46,89,1989
oral
mouse
lowest published toxic dose: 475 mg/kg (7 day male/7 day prior to copulation-21 day after birth) Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)

Reproductive: Effects on newborn: Biochemical and metabolic

Reproductive: Effects on newborn: Physical
GEPHDP 24,9,1993
subcutaneous
mouse
lowest published toxic dose: 1,240 mg/kg (12-13 day pregnant) Reproductive: Specific developmental abnormalities: Craniofacial (including nose and tongue) PSEBAA 144,644,1973
subcutaneous
rat
lowest published toxic dose: 28 mg/kg (14 day male) Reproductive: Other effects on male

Endocrine: Change in LH

Endocrine: Androgenic
LIFSAK 48,649,1991
subcutaneous
rat
lowest published toxic dose: 42 mg/kg (21 day male) Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) LIFSAK 48,649,1991


TUMORIGENIC DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
intraperitoneal
mouse
lowest published toxic dose: 882 mg/kg/7 day- intermittent Tumorigenic: Neoplastic by RTECS criteria

Blood: Lymphoma including Hodgkin's disease
PWPSA8 22,343,1979


ACUTE TOXICITY DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
intracerebral
mouse
lethal dose (50 percent kill): 14,040 g/kg Eye: Ptosis

Behavioral: Somnolence (general depressed activity)
NYKZAU 69,75,1973
intracerebral
rat
lethal dose (50 percent kill): 4,800 g/kg Behavioral: Altered sleep time (including change in righting reflex)

Behavioral: Somnolence (general depressed activity)

Nutritional and Gross Metabolic: Body temperature decrease
PJPPAA 26,399,1974
intraperitoneal
cat
lethal dose (50 percent kill): 492 mg/kg N/R RPTOAN 42,9,1979
intraperitoneal
guinea pig
lethal dose (50 percent kill): 624 mg/kg N/R STGNBT -,157,1999
intraperitoneal
guinea pig
lethal dose (50 percent kill): 624 mg/kg Olfaction: Deviated nasal septum

Eye: Lacrimation

Skin: After topical application: Primary irritation
VCVN1* -,26,1998
intraperitoneal
hamster
lowest published toxic dose: 169.6 mg/kg Endocrine: Change in LH IMSCE2 14,523,1986
intraperitoneal
mammal (species unspecified)
lowest published toxic dose: 390 mg/kg Gastrointestinal: Nausea or vomiting PSCHDL 171,156,2004
intraperitoneal
mouse
lethal dose (50 percent kill): 600 mg/kg Nutritional and Gross Metabolic: Body temperature decrease JTBIDS 6,87,1981
intraperitoneal
mouse
lethal dose (50 percent kill): 680 mg/kg Behavioral: Tetany

Lung, Thorax, or Respiration: Respiratory depression

Gastrointestinal: Hypermotility, diarrhea
VCVN1* -,26,1998
intraperitoneal
mouse
lowest published toxic dose: 635.9 mg/kg Endocrine: Change in LH

Endocrine: Change in gonadotropins
BRREAP 380,176,1986
intraperitoneal
mouse
lowest published toxic dose: 5 mg/kg Behavioral: Change in psychophysiological tests EJPHAZ 550,107,2006
intraperitoneal
rat
lethal dose (50 percent kill): 514 mg/kg N/R PetKP# 22DEC1977
intraperitoneal
rat
lethal dose (50 percent kill): 925 mg/kg Behavioral: Tetany

Lung, Thorax, or Respiration: Respiratory depression

Gastrointestinal: Hypermotility, diarrhea
VCVN1* -,26,1998
intraperitoneal
rat
lowest published toxic dose: 8.2 mg/kg Behavioral: Change in psychophysiological tests JPETAB 298,539,2001
intraperitoneal
rat
lowest published toxic dose: 110 mg/kg Brain and Coverings: Other degenerative changes

Liver: Other changes
FATOAO 44,531,1981
intraperitoneal
rat
lowest published toxic dose: 76 mg/kg Endocrine: Other changes EJPHAZ 489,111,2004
intraperitoneal
rat
lowest published toxic dose: 1,272 mg/kg Behavioral: Fluid intake PBBHAU 2,725,1974
intraperitoneal
rat
lowest published toxic dose: 63.6 mg/kg Brain and Coverings: Recordings from specific areas of CNS

Behavioral: Wakefulness

Behavioral: Altered sleep time (including change in righting reflex)
PBBHAU 5,547,1976
intraperitoneal
rat
lowest published toxic dose: 120 mg/kg Behavioral: Alteration of classical conditioning

Behavioral: Change in psychophysiological tests
PSCHDL 177,35,2004
intraperitoneal
rat
lowest published toxic dose: 127.182 mg/kg Taste: Change in function

Gastrointestinal: Nausea or vomiting
PSCHDL 190,135,2007
intratracheal
rat
lethal dose (50 percent kill): 205 mg/kg N/R STGNBT -,157,1999
intravenous
cat
lowest published toxic dose: 78.5 mg/kg Cardiac: Changes in coronary arteries FATOAO 49,63,1986
intravenous
dog
lowest published lethal dose: 500 mg/kg Behavioral: Food intake (animal)

Gastrointestinal: Changes in structure or function of salivary glands

Musculoskeletal: Other changes
JPETAB 100,429,1950
intravenous
mouse
lethal dose (50 percent kill): 363 mg/kg Brain and Coverings: Recordings from specific areas of CNS

Behavioral: Antipsychotic
OYYAA2 7,413,1973
oral
wild bird
lethal dose (50 percent kill): 422 mg/kg N/R AECTCV 12,355,1983
oral
human
lowest published lethal dose: 200 mg/kg/3 day Behavioral: Somnolence (general depressed activity)

Behavioral: Muscle weakness

Behavioral: Muscle contraction or spasticity
JAMAAP 139,688,1949
oral
human
lowest published toxic dose: 243 mg/kg/13 day Behavioral: Somnolence (general depressed activity)

Behavioral: Tremor

Gastrointestinal: Nausea or vomiting
JAMAAP 139,688,1949
oral
mouse
lethal dose (50 percent kill): 1,165 mg/kg Behavioral: Tetany

Lung, Thorax, or Respiration: Respiratory depression

Gastrointestinal: Hypermotility, diarrhea
VCVN1* -,26,1998
oral
mouse
lowest published toxic dose: 250 mg/kg Blood: Other changes

Nutritional and Gross Metabolic: Changes in: K
AEMME* 8,956,2001
oral
mouse
lethal dose (50 percent kill): 1,165 mg/kg N/R USXXAM #6365129
oral
quail
lethal dose (50 percent kill): 422 mg/kg N/R AECTCV 12,355,1983
oral
rat
lethal dose (50 percent kill): 1,530 mg/kg Behavioral: Tetany

Lung, Thorax, or Respiration: Respiratory depression

Gastrointestinal: Hypermotility, diarrhea
VCVN1* -,26,1998
oral
rat
lethal dose (50 percent kill): 526 mg/kg N/R USXXAM #6365129
oral
rabbit
lethal dose (50 percent kill): 800 mg/kg N/R FATOAO 39,53,1976
oral
rabbit
lethal dose (50 percent kill): 775 mg/kg Behavioral: Tetany

Lung, Thorax, or Respiration: Respiratory depression

Gastrointestinal: Hypermotility, diarrhea
VCVN1* -,26,1998
oral
rabbit
lowest published toxic dose: 850 mg/kg Brain and Coverings: Other degenerative changes

Liver: Other changes

Endocrine: Hyperglycemia
FATOAO 44,531,1981
subcutaneous
cat
lowest published lethal dose: 450 mg/kg N/R EQSSDX 1,1,1975
subcutaneous
frog
lowest published lethal dose: 885 mg/kg N/R HBAMAK 4,1289,1935
subcutaneous
guinea pig
lowest published lethal dose: 620 mg/kg N/R EQSSDX 1,1,1975
subcutaneous
mouse
lethal dose (50 percent kill): 738 mg/kg Behavioral: Tremor

Musculoskeletal: Other changes
APTOA6 43,51,1978
subcutaneous
mouse
lethal dose (50 percent kill): 970 mg/kg Behavioral: Tetany

Lung, Thorax, or Respiration: Respiratory depression

Gastrointestinal: Hypermotility, diarrhea
VCVN1* -,26,1998
subcutaneous
mouse
lowest published toxic dose: 400 mg/kg Peripheral Nerve and Sensation: Sensory change involving segmental distribution NEROEW 28,888,2003
subcutaneous
pigeon
lowest published lethal dose: 513 mg/kg N/R HBAMAK 4,1289,1935
subcutaneous
rat
lethal dose (50 percent kill): 499 mg/kg N/R PetKP# 22DEC1977
subcutaneous
rabbit
lowest published lethal dose: 531 mg/kg N/R EQSSDX 1,1,1975
subcutaneous
rabbit
lethal dose (50 percent kill): 700 mg/kg Behavioral: Tetany

Lung, Thorax, or Respiration: Respiratory depression

Gastrointestinal: Hypermotility, diarrhea
VCVN1* -,26,1998
skin
rat
lethal dose (50 percent kill): 1,488 mg/kg N/R VCVN1* -,28,1998
skin
rabbit
lethal dose (50 percent kill): 1,629 mg/kg Skin: After topical application: Primary irritation VCVN1* -,28,1998


OTHER MULTIPLE DOSE DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
inhalation
mammal (species unspecified)
lowest published toxic dose: 14 mg/m3/17 week- intermittent Brain and Coverings: Other degenerative changes

Olfaction: Other olfaction effects

Nutritional and Gross Metabolic: Weight loss or decreased weight gain
STGNBT -,157,1999
intraperitoneal
mouse
lowest published toxic dose: 40 mg/kg/4 day- intermittent Behavioral: Altered sleep time (including change in righting reflex) FATOAO 55,46,1992
intraperitoneal
mouse
lowest published toxic dose: 280 mg/kg/7 day- intermittent Behavioral: Alteration of classical conditioning

Endocrine: Differential effect of sex or castration on observed toxicity
CNREA8 66,11179,2006
intraperitoneal
rat
lowest published toxic dose: 500 mg/kg/10 day- intermittent Liver: Changes in liver weight

Kidney, Ureter, and Bladder: Urine volume increased

Endocrine: Changes in spleen weight
DPHFAK 23,439,1971
intraperitoneal
rat
lowest published toxic dose: 414 mg/kg/2 day- intermittent Endocrine: Change in LH LIFSAK 33,1621,1983
intraperitoneal
rat
lowest published toxic dose: 1,484 mg/kg/7 day- intermittent Endocrine: Change in gonadotropins LIFSAK 33,1621,1983
intraperitoneal
rat
lowest published toxic dose: 125 mg/kg/5 day- intermittent Endocrine: Change in gonadotropins

Endocrine: Androgenic
LIFSAK 40,1835,1987
intraperitoneal
rat
lowest published toxic dose: 175 mg/kg/5 day- intermittent Endocrine: Change in LH

Endocrine: Change in gonadotropins

Endocrine: Androgenic
LIFSAK 40,1835,1987
intraperitoneal
rat
lowest published toxic dose: 2,374 mg/kg/2 week- intermittent Brain and Coverings: Other degenerative changes

Nutritional and Gross Metabolic: Weight loss or decreased weight gain

Biochemical: Metabolism (intermediary): Amino acids (including renal excretion)
EURNE* 13,220,2003
intraperitoneal
rat
lowest published toxic dose: 25.4 mg/kg/2 day- intermittent Behavioral: Food intake (animal)

Behavioral: Alteration of classical conditioning
PBBHAU 37,497,1990
intraperitoneal
rat
lowest published toxic dose: 1,200 mg/kg/10 day- intermittent Brain and Coverings: Other degenerative changes

Biochemical: Metabolism (intermediary): Other proteins
EURNE* 14,497,2004
oral
dog
lowest published toxic dose: 4,200 mg/kg/42 day- intermittent Behavioral: Coma

Nutritional and Gross Metabolic: Weight loss or decreased weight gain

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
JPETAB 100,429,1950
oral
mammal (species unspecified)
lowest published toxic dose: 1,638 g/kg/26 week- intermittent Cardiac: Pulse rate increased without fall in BP

Liver: Liver function tests impaired

Blood: Changes in erythrocyte (RBC) count
STGNBT -,157,1999
oral
mouse
lowest published toxic dose: 1.92 gm/kg/4 day- continuous Endocrine: Effect on menstrual cycle BRREAP 380,176,1986
oral
rat
lowest published toxic dose: 2,849 mg/kg/4 week- continuous Behavioral: Fluid intake

Kidney, Ureter, and Bladder: Urine volume increased

Kidney, Ureter, and Bladder: Other changes
APTOA6 33,92,1973
oral
rat
lowest published toxic dose: 712 mg/kg/1 week- continuous Behavioral: Fluid intake

Nutritional and Gross Metabolic: Weight loss or decreased weight gain
APTOA6 52,81,1983
oral
rat
lowest published toxic dose: 6,499 mg/kg/5 week- continuous Kidney, Ureter, and Bladder: Urine volume increased

Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)

Nutritional and Gross Metabolic: Changes in: Na
APTOA6 35,337,1974
oral
rat
lowest published toxic dose: 2.1 gm/kg/35 day- intermittent Vascular: Relaxation (isolated tissue)

Vascular: Other changes
CEXPB9 27,55,2000
oral
rat
lowest published toxic dose: 360 mg/kg/15 day- continuous Endocrine: Changes in adrenal weight

Reproductive: Paternal effects: Prostate, seminal vesicle, Cowper's gland, accessory glands

Nutritional and Gross Metabolic: Weight loss or decreased weight gain
ANANAU 170,31,1990
oral
rat
lowest published toxic dose: 96 mg/kg/4 day- continuous Behavioral: Fluid intake

Kidney, Ureter, and Bladder: Urine volume increased
ANANAU 170,31,1990
oral
rat
lowest published toxic dose: 5.3 gm/kg/6 week- continuous Brain and Coverings: Other degenerative changes

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes
PSCHDL 158,80,2001
oral
rat
lowest published toxic dose: 382 mg/kg/3 day- continuous Brain and Coverings: Other degenerative changes

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
PSCHDL 162,379,2002
oral
rat
lowest published toxic dose: 2.67 gm/kg/3 week- continuous Brain and Coverings: Other degenerative changes

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
PSCHDL 162,379,2002
oral
rat
lowest published toxic dose: 8.9 gm/kg/28 day- intermittent Biochemical: Neurotransmitters or modulators (putative): Dopamine at other sites JOPSEQ 19,229,2005
subcutaneous
mouse
lowest published toxic dose: 5,440 mg/kg/17 day- intermittent Kidney, Ureter, and Bladder: Other changes in urine composition

Nutritional and Gross Metabolic: Weight loss or decreased weight gain

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
FATOAO 37,102,1974
subcutaneous
rat
lowest published toxic dose: 678 mg/kg/8 day- intermittent Behavioral: Fluid intake

Kidney, Ureter, and Bladder: Urine volume increased

Kidney, Ureter, and Bladder: Other changes in urine composition
FAATDF 18,616,1992
subcutaneous
rat
lowest published toxic dose: 3,561 mg/kg/28 day- continuous Brain and Coverings: Other degenerative changes

Biochemical: Metabolism (intermediary): Other proteins

Biochemical: Metabolism (intermediary): Effect on cyclic nucleotides
JOPSEQ 18,496,2004


REVIEWS:

ORGANIZATION STANDARD
REFERENCE

N/R N/R N/R


STANDARDS AND REGULATIONS:

ORGANIZATION STANDARD
REFERENCE

N/R N/R N/R


NIOSH DOCUMENTATION AND SURVEILLANCE:

ORGANIZATION STANDARD or SURVEY
REFERENCE

National Occupational Hazard Survey 1974 National Occupational Hazard Survey 1974: Hazard Code: 84472;
Number of Industries 26;
Total Number of Facilities 1,089;
Number of Occupations 25;
Total Number of Employees Exposed 5,881
National Occupational Exposure Survey 1983 National Occupational Exposure Survey 1983: Hazard Code: 84472;
Number of Industries 36;
Total Number of Facilities 2,291;
Number of Occupations 36;
Total Number of Employees Exposed 34,091;
Total Number of Female Employees Exposed 15,304


STATUS IN FEDERAL AGENCIES:

ORGANIZATION
REFERENCE

EPA GENETOX PROGRAM 1988, Negative: Cell transform.-SA7/SHE; B subtilis rec assay
EPA TSCA Section 8(b) CHEMICAL INVENTORY


REFERENCES:

CODEN
REFERENCE

28ZPAK "Sbornik Vysledku Toxixologickeho Vysetreni Latek A Pripravku," Marhold, J.V., Institut Pro Vychovu Vedoucicn Pracovniku Chemickeho Prumyclu Praha, Czechoslovakia, 1972
AECTCV Archives of Environmental Contamination and Toxicology. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 070944) V.1- 1973-
AEMME* Academic emergency medicine: official journal of the Society for Academic Emergency Medicine (Philadelphia Pa Hanley And Belfus) V.1- 1994-
ANANAU Anatomischer Anzeiger. (VEB Gustav Fischer Verlag, Postfach 176, Jena DDR-6900, Ger. Dem. Rep.) V.1- 1886-
APTOA6 Acta Pharmacologica et Toxicologica. (Copenhagen, Denmark) V.1-59, 1945-86. For publisher information, see PHTOEH
BRREAP Brain Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1966-
CEXPB9 Clinical and Experimental Pharmacology and Physiology. (Blackwell Scientific Publications, (Australia) Pty Ltd., 107 Barry St., Carlton, Vic. 3053, Australia) V.1- 1974-
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941-
CRSBAW Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849-
CYTOAN Cytologia. (Japan Pub. Trading Co. (USA), 1255 Howard St., San Francisco, CA 94103) V.1- 1929-
DEPBA5 Developmental Psychobiology. (John Wiley & Sons, Inc., 605 Third Ave., New York, NY 10158) V.1- 1968-
DPHFAK Dissertationes Pharmaceuticae et Pharmacologicae. (Warsaw, Poland) V.18-24, 1966-72. For publisher information, see PJPPAA.
EJPHAZ European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1967-
EQSSDX Environmental Quality and Safety, Supplement. (Stuttgart, Fed. Rep. Ger.) V.1-5, 1975-76. Discontinued.
EURNE* European Neuropsychopharmacology (Elsevier Science, P.O.Box 7247-7682,Philadelphia,PA 19170 -7682,USA OR Elsevier Science B.V.,P.O.Box 1270,1000 BG Amsterdam,The Netherlands) V.1- Nov.1990-
FAATDF Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-40, 1981-97. For publisher information, see TOSCF2
FATOAO Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939-
GEPHDP General Pharmacology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.6- 1975-
HBAMAK "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.)
IMSCE2 IRCS Medical Science. (Lancaster, UK) V.12-14, 1984-86. For publisher information, see MSCREJ.
JAMAAP JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883-
JOPSEQ Journal of Psychopharmacology (Oxford). (Oxford University Press, Great Clarendon St., Oxford OX2 6DP, UK) V.1- 1987-
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10-
JTBIDS Journal of Thermal Biology. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.1- 1975-
LIFSAK Life Sciences. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1-8, 1962-69; V.14- 1974-
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964-
MUTAEX Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986-
NEROEW Neuropsychopharmacology. (Elsevier Science, 655 Avenue of the Americas, New York, NY 10010) V.1- 1987-
NYKZAU Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40- 1944-
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967-
PBBHAU Pharmacology, Biochemistry and Behavior. (ANKHO International Inc., P.O. Box 426, Fayetteville, NY 13066) V.1- 1973-
PHBHA4 Physiology and Behavior. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1966-
PJPPAA Polish Journal of Pharmacology and Pharmacy. (ARS Polona, POB 1001, 00-068 Warsaw 1, Poland) V.25-44, 1973-92. For publisher information, see PJPAE3
PSCHDL Psychopharmacology (Berlin). (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.47- 1976-
PSEBAA Proceedings of the Society for Experimental Biology and Medicine. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04-
PWPSA8 Proceedings of the Western Pharmacology Society. (Univ. of California Dept. of Pharmacology, Los Angeles, CA 90024) V.1- 1958-
PetKP# Personal Communication from K.P. Petersen, DAK Labs., 59 Lergravsvej, DK-2300, Copenhagen, Demark, Dec. 22, 1977
RPTOAN Russian Pharmacology and Toxicology (English Translation). Translation of FATOAO. (Euromed Pub., 33, Woodlands Rd., Surbiton, Surrey, UK) V.30- 1967-
STGNBT "Spravochnik po Toksikologii i Gigienicheskim Normativam (PDK) Potentsial'no Opasnykh Khimicheskikh Veshchestv" Kushneva, V.S., and R.B. Gorshkova, eds. 46, Zhivopisnaya St., 123182, Moscow, Russia, IzdAT 1999
TJADAB Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968-
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231)
VCVN1* "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov I-IV groopp" (Hazardous substances. Inornanic substances containing I-IV group elements), Filov V.A., Chimia, 1988.

Used for dehumidification in air conditioning industry, also used to obtain lithium metal

NIOSH PROFILE (LITHIUM AND ITS COMPOUNDS), SRC, 4/78

RTECS Compound Description:
   Tumorigen
   Drug
   Mutagen
   Reproductive Effector
   Human Data
   Primary Irritant

Click Here for Additional Information about RTECS

NIOSH Home |  NIOSH Search  |  Site Index  |  Topic List |  Contact Us